| Earnings estimate | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2018) | Next year (2019) |
|---|---|---|---|---|
| No. of analysts | 0 | 0 | 0 | 0 |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low estimate | 0 | 0 | 0 | 0 |
| High estimate | 0 | 0 | 0 | 0 |
| Year ago EPS | 27.2 | 24.6 | N/A | N/A |
| Revenue estimate | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2018) | Next year (2019) |
|---|---|---|---|---|
| No. of analysts | 8 | 3 | 23 | 23 |
| Avg. Estimate | 7.92B | 7.67B | 30.55B | 31.5B |
| Low estimate | 7.77B | 7.53B | 30.1B | 30.81B |
| High estimate | 8.05B | 7.94B | 32.33B | 33.81B |
| Year ago sales | 7.64B | 7.22B | 30.19B | 30.55B |
| Sales growth (year/est) | 3.70% | 6.20% | 1.20% | 3.10% |
| Earnings history | 31/12/2017 | 31/03/2018 | 30/06/2018 | 30/09/2018 |
|---|---|---|---|---|
| Est. EPS | 25.98 | 24.25 | 26.07 | 33.18 |
| Actual EPS | 27.2 | 24.6 | 28.1 | 35.5 |
| Difference | 1.22 | 0.35 | 2.03 | 2.32 |
| Surprise % | 4.70% | 1.40% | 7.80% | 7.00% |
| EPS trend | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2018) | Next year (2019) |
|---|---|---|---|---|
| Current estimate | 0 | 0 | 0 | 0 |
| 7 days ago | 26.64 | 28.69 | 114.07 | 113.85 |
| 30 days ago | 26.64 | 28.69 | 114.07 | 113.85 |
| 60 days ago | 26.64 | 28.69 | 114.07 | 113.85 |
| 90 days ago | 26.64 | 28.69 | 114.07 | 113.85 |
| EPS revisions | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2018) | Next year (2019) |
|---|---|---|---|---|
| Up last 7 days | N/A | N/A | 1 | 1 |
| Up last 30 days | N/A | 1 | 5 | 3 |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | 1 | N/A | 1 | N/A |
| Growth estimates | GSK.L | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current qtr. | N/A | N/A | N/A | -0.00 |
| Next qtr. | N/A | N/A | N/A | 0.08 |
| Current year | N/A | N/A | N/A | 0.03 |
| Next year | N/A | N/A | N/A | 0.10 |
| Next 5 years (per annum) | 4.86% | N/A | N/A | 0.08 |
| Past 5 years (per annum) | N/A | N/A | N/A | N/A |